TOB1 Activators
The class of TOB1 activators encompasses a diverse range of chemicals that indirectly influence the activity of TOB1 through various signaling pathways. TOB1, primarily known for its role in cellular processes like proliferation and apoptosis, does not directly interact with small molecule activators. Hence, the focus is on chemicals that modulate the signaling pathways intersecting with TOB1's function.
Most TOB1 activators work by either inhibiting or activating key enzymes or receptors in pathways like PI3K/AKT, MAPK/ERK, and JNK, which are crucial for the downstream regulation of TOB1. For example, PI3K inhibitors like LY294002 and Wortmannin lead to changes in AKT activity, which is known to cross-talk with TOB1-related pathways. Similarly, MEK inhibitors such as PD98059 and U0126 impact the MAPK/ERK pathway, influencing TOB1 indirectly. These modulations can lead to alterations in TOB1's role in cell proliferation, differentiation, and apoptosis. Another aspect of TOB1 activation involves epigenetic modulators like Trichostatin A and 5-Azacytidine. These chemicals do not target TOB1 directly but influence the expression levels and activity of TOB1 by altering chromatin structure and DNA methylation patterns, respectively. This approach represents a more systemic method of modulating TOB1 activity, offering a broader scope of regulation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a labdane diterpene from the Indian Coleus plant. It activates adenylyl cyclase, increasing cAMP levels, which can indirectly affect TOB1 activity through related signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinases (PI3Ks) inhibitor. It indirectly affects TOB1 activity via the PI3K/AKT signaling pathway, which intersects with TOB1-regulated pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that indirectly influences TOB1 activity by affecting the MAPK/ERK pathway, implicated in TOB1 regulation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 specifically inhibits p38 MAP kinase. The p38 MAP kinase pathway is a potential indirect modulator of TOB1 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits c-Jun N-terminal kinase (JNK). JNK signaling overlaps with TOB1 regulatory mechanisms, potentially impacting TOB1 activity indirectly. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3K inhibitor. It influences the signaling pathways regulating TOB1 by modulating PI3K activity. | ||||||
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 | 612847-09-3 | sc-202048 sc-202048A | 1 mg 5 mg | $208.00 $270.00 | 29 | |
This inhibitor targets Akt in the PI3K/AKT pathway. Its inhibition can indirectly modulate TOB1 activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that modulates gene expression, potentially affecting TOB1 activity indirectly. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor. It influences TOB1 activity indirectly by altering DNA methylation patterns. | ||||||